Dr. Rita Nanda, MD
Claim this profileUniversity of Chicago Comprehensive Cancer Center
Expert in Breast Cancer
Studies Cancer
24 reported clinical trials
47 drugs studied
About Rita Nanda, MD
Education:
- Received MD from the University of Chicago Pritzker School of Medicine.
Experience:
- Has been practicing since 2005.
- Principal investigator for the Translational Breast Cancer Research Consortium (TBCRC) and the I-SPY 2 trial.
- Leads the University of Chicago Medicine's breast cancer clinical trial program.
- Research focuses on new treatments for advanced breast cancer, with funding from notable organizations.
- Board-certified in Medical Oncology.
Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
2Cancer
Stage III
Stage IV
HER2 negative
Affiliated Hospitals
Clinical Trials Rita Nanda, MD is currently running
New Treatments
for Metastatic Breast Cancer
This trial is testing different medicines or combinations of medicines to treat cancer. It focuses on patients with certain solid tumors, including breast cancer. The study aims to find the safest and most effective dose and then tests that dose on more patients to see if it works. Dinaciclib is being evaluated for its potential in combination therapies for breast cancer.
Recruiting1 award Phase 110 criteria
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has spread, or metastasized, to other parts the body and is PD-L1-negative. The names of the study interventions involved in this study are: * Sacituzumab govitecan (Trodelvy™;IMMU-132) * Pembrolizumab (Keytruda®; MK-3475)
Recruiting1 award Phase 215 criteria
More about Rita Nanda, MD
Clinical Trial Related7 years of experience running clinical trials · Led 24 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Rita Nanda, MD has experience with
- Pembrolizumab
- Trastuzumab
- Mifepristone
- Atezolizumab
- Sacituzumab Govitecan
- Olaparib
Breakdown of trials Rita Nanda, MD has run
Breast Cancer
Cancer
Breast cancer
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rita Nanda, MD specialize in?
Rita Nanda, MD focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Rita Nanda, MD currently recruiting for clinical trials?
Yes, Rita Nanda, MD is currently recruiting for 6 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Rita Nanda, MD has studied deeply?
Yes, Rita Nanda, MD has studied treatments such as Pembrolizumab, Trastuzumab, Mifepristone.
What is the best way to schedule an appointment with Rita Nanda, MD?
Apply for one of the trials that Rita Nanda, MD is conducting.
What is the office address of Rita Nanda, MD?
The office of Rita Nanda, MD is located at: University of Chicago Comprehensive Cancer Center, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.